| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| February 19, 2008 | Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 18,750 | $5.50 | 467,500 | |
| February 19, 2008 | Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 18,750 | $5.50 | 448,750 | |
| June 20, 2014 | Director, CEO | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 140,556 | -- | 443,885 | |
| March 15, 2006 | President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,000 | -- | 442,334 | |
| June 15, 2020 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 55,000 | -- | 439,951 | |
| June 15, 2020 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 439,951 | |
| January 3, 2007 | President, CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 430,000 | $2.42 | 430,000 | |
| June 9, 2004 | Senior Vice President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400,000 | -- | 400,000 | |
| May 6, 2013 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,000 | -- | 385,000 | |
| October 3, 2019 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 35,000 | -- | 384,951 | |
| December 10, 2012 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 14,000 | $7.60 | 380,385 | |
| September 20, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,735 | $4.22 | 366,385 | |
| February 11, 2014 | CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 358,885 | |
| May 14, 2019 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 349,951 | |
| September 20, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,542 | $2.77 | 347,650 | |
| February 19, 2019 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 325,047 | |
| February 19, 2019 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 324,951 | |
| March 17, 2023 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 90,000 | -- | 320,000 | |
| February 22, 2005 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,000 | -- | 320,000 | |
| September 6, 2016 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,663 | -- | 316,213 | |
| September 20, 2012 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,083 | $3.25 | 313,108 | |
| September 6, 2016 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 29,332 | -- | 305,996 | |
| May 15, 2018 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 305,047 | |
| June 15, 2012 | CMO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,250 | $2.15 | 305,000 | |
| May 15, 2018 | CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 304,951 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
